Efficacy of cariprazine on predominant negative symptoms of patients with schizophrenia: post hoc analysis of PANSS data, Marder factors, and cognition

被引:7
作者
Marder, S. [1 ]
Laszlovszky, I. [2 ]
Szalai, E. [2 ]
Szatmari, B. [2 ]
Harsanyi, J. [2 ]
Barabassy, A. [2 ]
Debelle, M. [2 ]
Durgam, S. [3 ]
Bitter, I. [4 ]
Nemeth, G. [2 ]
机构
[1] Univ Calif Los Angeles, Semel Inst, Sect Psychosis, Los Angeles, CA USA
[2] Gedeon Richter Plc, Med Div, Budapest, Hungary
[3] Forest Res Inst, Clin Dev, Jersey City, NJ USA
[4] Semmelweis Univ, Dept Psychiat & Psychotherapy, Budapest, Hungary
关键词
D O I
10.1016/S0924-977X(16)31595-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.3.d.036
引用
收藏
页码:S550 / S550
页数:1
相关论文
共 50 条
[31]   Cariprazine as monotherapy for the treatment of schizophrenia patients with predominant negative symptoms: a double-blind, active controlled trial [J].
Debelle, M. ;
Nemeth, G. ;
Szalai, E. ;
Szatmari, B. ;
Harsanyi, J. ;
Barabassy, A. ;
Laszlovszky, I. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 :S510-S510
[32]   Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms [J].
Demyttenaere, Koen ;
Leenaerts, Nicolas ;
Acsai, Karoly ;
Sebe, Barbara ;
Laszlovszky, Istvan ;
Barabassy, Agota ;
Fonticoli, Laura ;
Szatmari, Balazs ;
Earley, Willie ;
Nemeth, Gyorgy ;
Correll, Christoph U. .
EUROPEAN PSYCHIATRY, 2021, 65 (01)
[33]   Efficacy of paliperidone extended-release tablets in patients with schizophrenia and predominant negative symptoms [J].
Dirks, B. ;
Eerdekens, M. ;
Turkoz, I. ;
Alberio, R. ;
Gharabawi, G. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 :S162-S162
[34]   Cariprazine in negative symptoms of schizophrenia: post hoc analyses of a fixed-dose, placebo- and active-controlled trial [J].
Debelle, M. ;
Faradzs-zade, S. ;
Szatmari, B. ;
Nagy, K. ;
Nemeth, G. ;
Durgam, S. ;
Laszlovszky, I. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 :S534-S534
[35]   Cariprazine as Monotherapy for the Treatment of Predominant Negative Symptoms of Patients with Schizophrenia: A Double-Blind, Active Comparator-Controlled Trial [J].
Debelle, Marc ;
Kahn, Rene ;
Laszlovszky, Istvan ;
Szalai, Erzsebet ;
Nemeth, Gyoergy ;
Szatmari, Balazs ;
Harsanyi, Judit ;
Barabassy, Gota ;
Durgam, Suresh ;
Fleischhacker, Wolfgang .
NEUROPSYCHOPHARMACOLOGY, 2015, 40 :S235-S236
[36]   Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial [J].
Nemeth, Gyorgy ;
Laszlovszky, Istvan ;
Czobor, Pal ;
Szalai, Erzsebet ;
Szatmari, Balazs ;
Harsanyi, Judit ;
Barabssy, Agota ;
Debelle, Marc ;
Durgam, Suresh ;
Bitter, Istvan ;
Marder, Stephen ;
Fleischhacker, W. Wolfgang .
LANCET, 2017, 389 (10074) :1103-1113
[37]   Cost-utility analysis of cariprazine compared to risperidone among patients with negative symptoms of schizophrenia [J].
Nemeth, Bertalan ;
Bendes, Rita ;
Nagy, Balazs ;
Gotze, Arpad ;
Koczian, Kristof ;
Horvath, Margit ;
Deak, Izabella ;
Toth, Bernadett ;
Kalo, Zoltan .
HEALTH POLICY AND TECHNOLOGY, 2019, 8 (01) :84-91
[38]   The efficacy of cariprazine on function in patients with bipolar depression: a post hoc analysis of a randomized controlled trial [J].
Vieta, Eduard ;
Calabrese, Joseph R. ;
Whelan, Jessica ;
Tohen, Mauricio ;
Earley, Willie R. .
CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) :1635-1643
[39]   Cariprazine for Negative Symptoms of Schizophrenia: Pooled Post Hoc Analysis of 2 Randomized, Double-Blind, Placebo- and Active-Controlled Trials [J].
Earley, Willie ;
Durgam, Suresh ;
Debelle, Marc ;
Laszlovszky, Istvan ;
Lu, Kaifeng ;
Nasrallah, Henry .
NEUROPSYCHOPHARMACOLOGY, 2015, 40 :S233-S234
[40]   Cariprazine for negative symptoms of schizophrenia: pooled post hoc analysis of 2 randomized, double-blind, placebo- and active-controlled trials [J].
Durgam, S. ;
Earley, W. ;
Lu, K. ;
Nemeth, G. ;
Laszlovszky, I. ;
Szatmari, B. ;
Edwards, J. ;
Nasrallah, H. A. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 :S552-S552